Novozymes is a listed Danish biosolutions company that uses biotechnology to deliver innovative and sustainable solutions to over 40 industries. With 700 products marketed in 130 countries, over 6,000 patents and 5,000 employees, Novozymes invests 14% of its ~ $2 billion annual revenues into ongoing research and development to maintain its leadership position in bioinnovation globally.
Novozymes offers the leading technology platform for bioethanol production, and has invested heavily in the development of next-generation
cellulosic ethanol, biodiesel and biogas technologies. Novozymes plays an integral role in the move towards sustainable agriculture, with enzymatic pesticides, microbial yield and fertility enhancers assisting farmers to enjoy healthier crops and higher yields.
Novozymes is a strategic technical, capability and financial partner in CleanStar Mozambique.